MedTrace Logo

Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes

NCT00506662 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2023-08-14

Study results available
· View outcomes & findings →

Summary

This trial is conducted in Europe. The aim of the trial is to compare insulin detemir once daily to NPH insulin once daily as measured by blood sugar control in ageing subjects with type 2 diabetes naive to previous insulin therapy.

Conditions

Interventions

DRUG

insulin detemir

Treat-to-target, s.c. (under the skin) injection, once daily

DRUG

insulin NPH

Treat-to-target, s.c. (under the skin) injection, once daily

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • France
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00506662 on ClinicalTrials.gov